About Us
VascuBio addresses a crucial gap in drug development: the need for reliable, human-mimetic models prior to clinical trials. Traditional drug development is costly, time-intensive, and has a high failure rate, underscoring an urgent need for efficient, predictive, and affordable preclinical testing.
VascuBio’s advanced bioreactor systems provide a solution, enabling faster, more reliable drug testing through human-mimetic, 3D bioprinted vascular tissue models.
Our bioreactor technology integrates cutting-edge materials and advanced monitoring to simulate real human physiological conditions. With innovations such as multiplex perfusion, automated rotation, and real-time monitoring, VascuBio’s bioreactors tackle the pharmaceutical industry's key pain points, creating an efficient and scalable platform for drug development.
Our mission is to set a new standard in preclinical drug testing, ultimately improving outcomes for patients worldwide.
